LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Erratum for Peloquin et al., “Pharmacokinetic Evidence from the HIRIF Trial To Support Increased Doses of Rifampin for Tuberculosis”

Photo by freestocks from unsplash

C. A. Peloquin,a G. E. Velásquez,b,c L. Lecca,c,d R. I. Calderón,d J. Coit,b M. Milstein,b E. Osso,b J. Jimenez,d K. Tintaya,d E. Sanchez Garavito,e D. Vargas Vasquez,f C. D. Mitnick,c,g… Click to show full abstract

C. A. Peloquin,a G. E. Velásquez,b,c L. Lecca,c,d R. I. Calderón,d J. Coit,b M. Milstein,b E. Osso,b J. Jimenez,d K. Tintaya,d E. Sanchez Garavito,e D. Vargas Vasquez,f C. D. Mitnick,c,g G. Daviesh University of Florida College of Pharmacy and Emerging Pathogens Institute, Gainesville, Florida, USAa; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USAb; Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USAc; Socios En Salud, Lima, Perud; Hospital Nacional Sergio Bernales, Lima, Perue; Hospital Nacional Hipólito Unanue, Lima, Peruf; Partners In Health, Boston, Massachusetts, USAg; Institutes of Infection and Global Health and Translational Medicine, University of Liverpool, Liverpool, United Kingdomh

Keywords: medicine; peloquin; boston massachusetts; peloquin pharmacokinetic; erratum peloquin; pharmacokinetic evidence

Journal Title: Antimicrobial Agents and Chemotherapy
Year Published: 2017

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.